Viewing StudyNCT00878930



Ignite Creation Date: 2024-05-05 @ 9:22 PM
Last Modification Date: 2024-10-26 @ 10:04 AM
Study NCT ID: NCT00878930
Status: COMPLETED
Last Update Posted: 2011-01-05
First Post: 2009-04-08

Brief Title: Parameters of Acceptability Compliance and Efficacy of Fulvestrant in Post-menopausal Patients With Advance Breast Cancer
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
Breast cancer View
Fulvestrant View
Faslodex View
Acceptability View
Compliance View
Efficacy View